Cargando…

Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?

Background: Although aminoglycosides are often used as treatment for Gram-negative infections, optimal dosing regimens remain unclear, especially in ICU patients. This is due to a large between- and within-subject variability in the aminoglycoside pharmacokinetics in this population. Objective: This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duong, Alexandre, Simard, Chantale, Wang, Yi Le, Williamson, David, Marsot, Amélie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145041/ https://www.ncbi.nlm.nih.gov/pubmed/33946905 http://dx.doi.org/10.3390/antibiotics10050507

Ejemplares similares

Model Re-Estimation: An Alternative for Poor Predictive Performance during External Evaluations? Example of Gentamicin in Critically Ill Patients
por: Duong, Alexandre, et al.
Publicado: (2022)

Prescription of Aminoglycosides in 23 French Neonatal Intensive Care Units
por: Martin-Mons, Séverine, et al.
Publicado: (2021)

Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt
por: Kishk, Rania, et al.
Publicado: (2021)

Risk factors for aminoglycoside-associated nephrotoxicity in surgical intensive care unit patients
por: Gerlach, Anthony T, et al.
Publicado: (2011)

1406. Augmented Renal Clearance Using Aminoglycoside Population-Based Pharmacokinetic Modeling with Bayesian Estimation in Children in the Pediatric Intensive Care Unit
por: Avedissian, Sean, et al.
Publicado: (2018)

Evaluation of aminoglycosides utilization in intensive care units of a teaching hospital in southern Iran
por: Vazin, Afsaneh, et al.
Publicado: (2019)

Variability in aminoglycoside dosing in intensive care units across London - should our methods be standardised?
por: Singleton, JM, et al.
Publicado: (2015)

Aminoglycoside use and intensive care unit-acquired weakness: A systematic review and meta-analysis
por: Yang, Tao, et al.
Publicado: (2020)

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care
por: McDermott, John H., et al.
Publicado: (2022)

β-Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study
por: Guilhaumou, Romain, et al.
Publicado: (2023)

2562. Re-Appraisal of Aminoglycoside (AG) Susceptibility Testing Breakpoints Based on the Application of Pharmacokinetics–Pharmacodynamics (PK-PD) and Contemporary Microbiology Surveillance Data
por: Bhavnani, Sujata M, et al.
Publicado: (2018)

Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics
por: Chittapragada, Maruthi, et al.
Publicado: (2009)

Investigation of carbapenemases and aminoglycoside modifying enzymes of Acinetobacter baumannii isolates recovered from patients admitted to intensive care units in a tertiary-care hospital in Brazil
por: Polotto, Milena, et al.
Publicado: (2019)

Measurements in the intensive care unit: what do they mean?
por: Marshall, John C
Publicado: (2003)

Unplanned extubation in the intensive care unit: what are the consequences?
por: Vianna, A, et al.
Publicado: (2007)

Police in an intensive care unit: what can happen?
por: Lynøe, Niels, et al.
Publicado: (2013)

Population PK and Semimechanistic PK/PD Modeling and Simulation of Relugolix Effects on Testosterone Suppression in Men with Prostate Cancer
por: Lee, Tien‐Yi, et al.
Publicado: (2022)

Damage control in the intensive care unit: what should the intensive care physician know and do?
por: Vargas, Mónica, et al.
Publicado: (2021)

Aminoglycoside riboswitch control of the expression of integron associated aminoglycoside resistance adenyltransferases
por: Zhang, Jun, et al.
Publicado: (2020)

What’s new in intensive care: environmental sustainability
por: Bein, Thomas, et al.
Publicado: (2021)

What’s new in intensive care: disease tolerance
por: Powell, Rachel E., et al.
Publicado: (2023)

Aminoglycoside interactions and impacts on the eukaryotic ribosome
por: Prokhorova, Irina, et al.
Publicado: (2017)

Complete Genome Sequence of the Pokeweed Mosaic Virus (PkMV)-New Jersey Isolate and Its Comparison to PkMV-MD and PkMV-PA
por: Di, Rong
Publicado: (2016)

Potential for the Development of a New Generation of Aminoglycoside Antibiotics
por: Tevyashova, A. N., et al.
Publicado: (2022)

Aminoglycoside Allergic Reactions
por: Childs-Kean, Lindsey M., et al.
Publicado: (2019)

Parallel pathways in the biosynthesis of aminoglycoside antibiotics
por: Yu, Yi, et al.
Publicado: (2017)

Aminoglycoside resistance profile and structural architecture of the aminoglycoside acetyltransferase AAC(6')-Im
por: Smith, Clyde A., et al.
Publicado: (2017)

Aminoglycoside resistance mechanism inference algorithm: Implication for underlying resistance mechanisms to aminoglycosides
por: Touati, Abdelaziz
Publicado: (2019)

Characterization of prickle isoform-specific pk (pk1) and pk (sple1) mutations in Drosophila melanogaster
por: Lilienthal, Anthony J, et al.
Publicado: (2022)

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J, et al.
Publicado: (2020)

Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese Population
por: Ross, Ashley L., et al.
Publicado: (2013)

Population-based inference of aminoglycoside resistance mechanisms in Escherichia coli
por: Mancini, Stefano, et al.
Publicado: (2019)

What Are the Current Approaches to Optimising Antimicrobial Dosing in the Intensive Care Unit?
por: Chai, Ming G., et al.
Publicado: (2020)

Resource-rich Intensive Care Units Improve Health―What Is Next?
por: Shime, Nobuaki
Publicado: (2022)

To what extent are children harmed by medications in pediatric intensive care units?
Publicado: (2022)

New concepts in palliative care in the intensive care unit
por: Coelho, Cristina Bueno Terzi, et al.
Publicado: (2017)

New concepts for bringing urine biochemistry back to clinical practice in the intensive care unit
por: Maciel, Alexandre Toledo
Publicado: (2014)

Palliative care in intensive care units: why, where, what, who, when, how
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Intensivists’ perceptions of what is missing in their compassionate care during interactions in the intensive care unit
por: Siddiqui, Shahla, et al.
Publicado: (2022)

Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance
por: Clark, Justin A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vviseed4jgfck46qhj19aukfgh